Roman Butler Fullerton & Co. bought a new position in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 7,143 shares of the real estate investment trust’s stock, valued at approximately $542,000.
Other institutional investors also recently bought and sold shares of the company. Renaissance Group LLC lifted its position in shares of National Health Investors by 3.8% in the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after buying an additional 117 shares during the last quarter. Captrust Financial Advisors increased its holdings in shares of National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock valued at $680,000 after acquiring an additional 146 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after acquiring an additional 160 shares during the last quarter. Assetmark Inc. raised its stake in shares of National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock valued at $110,000 after acquiring an additional 161 shares in the last quarter. Finally, Inspire Investing LLC raised its stake in shares of National Health Investors by 3.2% in the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust’s stock valued at $510,000 after acquiring an additional 198 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the purchase, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.
National Health Investors Stock Down 0.1%
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm had revenue of $121.32 million during the quarter. During the same period last year, the company earned $1.22 EPS. The company’s revenue was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts anticipate that National Health Investors, Inc. will post 4.77 earnings per share for the current year.
National Health Investors Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. National Health Investors’s payout ratio is currently 106.36%.
Wall Street Analysts Forecast Growth
NHI has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research note on Wednesday, April 22nd. Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of “Moderate Buy” and a consensus price target of $83.86.
View Our Latest Stock Report on National Health Investors
About National Health Investors
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
See Also
- Five stocks we like better than National Health Investors
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
